5-甲氧基-3-甲酰基吲哚-1-羧酸叔丁酯 | 324756-80-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 5-甲氧基-3-甲酰基吲哚-1-羧酸叔丁酯
• 英文名称: tert-butyl 3-formyl-5-methoxy-1H-indole-1-carboxylate
• 英文别名: tert-butyl 3-formyl-5-methoxyindole-1-carboxylate
• CAS: 324756-80-1
• 化学式: C₁₅H₁₇NO₄
• 分子量: 275.304
• InChiKey: RVKRRKYBGKPJDF-UHFFFAOYSA-N

物化性质

• 熔点：
  138-140°

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  57.5
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C，保持在惰性气体氛围中。

反应信息

• 作为反应物：
  描述：

  5-甲氧基-3-甲酰基吲哚-1-羧酸叔丁酯 在 三乙酰氧基硼氢化钠 、 potassium carbonate 、 溶剂黄146 作用下， 以 甲醇 、 1,2-二氯乙烷 为溶剂， 反应 1.0h， 生成 1-(4-fluorophenyl)-1-(3-(((5-methoxy-1H-indol-3-yl)methyl)-(methyl)amino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile
  参考文献：
  名称：

  Design and Synthesis of 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (Citalopram) Analogues as Novel Probes for the Serotonin Transporter S1 and S2 Binding Sites

  摘要：

  The serotonin transporter (SERT) is the primary target for antidepressant drugs. The existence of a high affinity primary orthosteric binding site (S1) and a low affinity secondary site (S2) has been described, and their relation to antidepressant pharmacology has been debated. Herein, structural modifications to the N, 4, 5, and 4' positions of (+/-)citalopram (1) are reported. All of the analogues were SERT-selective and demonstrated that steric bulk was tolerated at the SERT Si site, including two dimeric ligands (15 and 51). In addition, eight analogues were identified with similar potencies to S-1 for decreasing the dissociation of [H-3]S-1 from the S1 site via allosteric modulation at S2. Both dimeric compounds had similar affinities for the SERT Si site (K-i = 19.7 and 30.2 nM, respectively), whereas only the N-substituted analogue, 51, was as effective as S-1 in allosterically modulating the binding of [H-3]S-1 via S2.

  DOI：

  10.1021/jm4014136
• 作为产物：
  描述：

  5-甲氧基吲哚 在 4-二甲氨基吡啶 、 三氯氧磷 作用下， 以 四氢呋喃 为溶剂， 反应 14.0h， 生成 5-甲氧基-3-甲酰基吲哚-1-羧酸叔丁酯
  参考文献：
  名称：

  Sarpagine 和 Koumine 生物碱的不对称全合成

  摘要：

  我们在这里报告了一种简洁、集体和不对称的沙巴碱生物碱和生物遗传学相关的 koumine 生物碱的全合成，其结构特点是刚性笼支架，L-色氨酸作为起始材料。两个关键的桥接骨架形成反应，即串联顺序氧化环丙醇开环环化和酮 α-烯丙基化，确保笼式 sarpagine 支架的同时组装和必要的衍生手柄的安装。以共同的笼状中间体为分支点，利用其中的酮基和丙二烯基，全合成五种沙巴碱生物碱（affinisine、normacusine B、trinervine、N a-methyl-16-epipericyclivine 和 vellosimine）和三种 koumine 生物碱（koumine、koumimine 和N- demethylkoumine ）和更复杂的笼支架已经完成。

  DOI：

  10.1002/anie.202102416

文献信息

• Gold(I)‐Catalyzed Selective Cyclization and 1,2‐Shift to Prepare Pseudorutaecarpine Derivatives
  作者：Wang Wang、Nan‐Ying Chen、Pei‐Sen Zou、Li Pang、Dong‐Liang Mo、Cheng‐Xue Pan、Gui‐Fa Su

  DOI：10.1002/adsc.202101054

  日期：2022.2.15

  pseudorutaecarpine derivatives were prepared in good to excellent yields through a gold(I)-catalyzed selective cyclization and 1,2-shift of N-alkynyl quinazolinone-tethered indoles. Mechanistic study revealed that spiroindolenines generated in situ by cyclization at the the indole C3 position underwent an alkenyl 1,2-shift to generate pseudorutaecarpine. The reaction proceeds under mild reaction conditions

  通过金 (I) 催化的选择性环化和N-炔基喹唑啉酮系链吲哚的 1,2-位移，以良好至优异的产率制备了多种假芸香碱衍生物。机理研究表明，通过在吲哚C3位环化原位产生的螺二氢吲哚经过烯基1,2-移位生成假芸香碱。该反应在温和的反应条件下进行，具有广泛的底物范围、良好的官能团耐受性和克级规模的应用。此外，生物学评估表明，大多数制备的假芸香碱支架具有抗炎活性。
• One‐Pot Oxidation of Secondary Alcohols to <i>α</i> ‐Hydroxy Ketones: Application to Synthesis of Oxoaplysinopsin D, E, F, &amp; G
  作者：Akshay S. Kulkarni、Eagala Ramesh、D. Srinivasa Reddy

  DOI：10.1002/ejoc.202100184

  日期：2021.4.22

  A one‐pot method for the transformation of secondary alcohols to α‐hydroxy ketones using pyridinium dichromate (PDC) at room temperature is described. The method was tested with a variety of hydantoin derivatives. As a direct application, total synthesis of four natural oxoaplysinopsins D, E, F and G was accomplished for the first time through a common dihydroxy intermediate.

  描述了一种在室温下使用重铬酸吡啶鎓（PDC）将仲醇转化为α-羟基酮的一锅法。用多种乙内酰脲衍生物测试了该方法。作为直接的应用，四种天然的氧代皂甙酶D，E，F和G的全合成是通过共同的二羟基中间体首次完成的。
• Three-Component One-Pot Synthesis of 3-(2-Furanyl)indoles from Acetylenedicarboxylate, Isocyanide, and 3-Formylindole
  作者：B. Reddy、A. Reddy、D. Somashekar、J. Yadav、B. Sridhar

  DOI：10.1055/s-0029-1218824

  日期：2010.8

  The zwitterions derived from isocyanide and dimethyl acetylenedicarboxylate undergo smooth condensation with 3-formylindoles in benzene at room temperature to give the corresponding 3-(2-furanyl)indoles in good yields. This method provides a simple and convenient route to produce a wide range of 3-heteroarylindoles in a one-pot operation.

  来自异氰和二甲基乙炔二羧酸酯的半缩醛与3-甲醛基吲哚在室温下的苯溶液中顺利进行缩合反应，以良好产率得到相应的3-(2-呋喃基)吲哚。此方法提供了一种简单方便的途径，通过一锅法操作制备多种3-杂芳基吲哚。
• Iridium-Catalyzed Direct Regioselective C4-Amidation of Indoles under Mild Conditions
  作者：Shuyou Chen、Boya Feng、Xuesong Zheng、Jiangliang Yin、Shiping Yang、Jingsong You

  DOI：10.1021/acs.orglett.7b00730

  日期：2017.5.19

  An efficient Ir-catalyzed amidation of indoles with sulfonyl azides is disclosed, affording diverse C4-amidated indoles exclusively under mild conditions. In this protocol, a variety of indoles with commonly occurring functional groups such as formyl, acetyl, carboxyl, amide, and ester at the C3 position are well tolerated.

  公开了一种用磺酰叠氮化物有效地将吲哚用铱催化的酰胺化酰胺，仅在温和条件下提供各种C 4酰胺化的吲哚。在该协议中，对在C3位置具有常见官能团（如甲酰基，乙酰基，羧基，酰胺和酯）的各种吲哚都具有良好的耐受性。
• [EN] VIRAL REPLICATION INHIBITORS<br/>[FR] INHIBITEURS DE REPLICATION VIRALE
  申请人：UNIV LEUVEN KATH

  公开号：WO2013045516A1

  公开（公告）日：2013-04-04

  The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.

  本发明涉及一系列新化合物，通过使用这些新化合物来预防或治疗动物的病毒感染的方法，以及将这些新化合物用作药物，更好地用于治疗或预防病毒感染，特别是感染RNA病毒，更特别是感染属于黄病毒科的病毒，更特别是感染登革病毒。本发明还涉及这些新化合物的药物组合或混合制剂，用作药物的组合或制剂，更好地用于预防或治疗病毒感染。该发明还涉及这些化合物的制备方法。